FDA clears Siemens' 2-in-1 medical scanner

Jun 10, 2011

(AP) -- The Food and Drug Administration says it has cleared the first medical imaging device to simultaneously perform two powerful scans used to diagnose a wide variety of diseases and ailments.

The agency says Siemens' Biograph mMR system runs both a positron emission tomography scan, known as a PET scan, and a scan, or MRI scan. The combination is expected to save time and reduce patients' exposure to radiation.

Older devices combine a and computer tomography, which uses high-powered X-ray scans. Siemens' device replaces that technology with the MRI, which does not contain radiation.

MRI scans use magnetic fields to produce detailed images of organs, bones and other internal structures. PET scans work with a radioactive injection to trace blood flow throughout the body.

Explore further: Analgesics prescribed more heavily to women than to men, study finds

not rated yet
add to favorites email to friend print save as pdf

Related Stories

MRI/PET scanner combo

Mar 07, 2008

Two kinds of body imaging -- positron emission tomography (PET) and magnetic resonance imaging (MRI) -- have been combined for the first time in a single scanner.

New scans improve treatment accuracy

Sep 14, 2006

Australian doctors say they have developed new scans that can that quickly show whether breast cancer cells are responding to therapy.

Recommended for you

New sleeping pill poised to hit US markets

15 hours ago

An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.

Global recommendations on child medicine

16 hours ago

Transparent information on the evidence supporting global recommendations on paediatric medicines should be easily accessible in order to help policy makers decides on what drugs to include in their national drug lists, according ...

FDA has safety concerns on Merck insomnia drug

May 20, 2013

Federal health regulators say an experimental insomnia drug from Merck can help patients fall asleep, but it also carries worrisome side effects, including daytime drowsiness and suicidal thinking.

User comments : 0

More news stories

Theorists weigh in on where to hunt dark matter

(Phys.org) —Now that it looks like the hunt for the Higgs boson is over, particles of dark matter are at the top of the physics "Most Wanted" list. Dozens of experiments have been searching for them, but ...

DNA damage: The dark side of respiration

(Phys.org) —Adventitious changes in cellular DNA can endanger the whole organism, as they may lead to life-threatening illnesses like cancer. Researchers at LMU now report how byproducts of respiration cause mispairing ...